Loading…

Loading grant details…

Completed H2020 European Commission

Identification of molecular targets of psychoactive kavalactones using iBodies

€157K EUR

Funder European Commission
Recipient Organization Ustav Organicke Chemie A Biochemie, Av Cr, V.V.I.
Country Czech Republic
Start Date Jan 01, 2021
End Date Dec 30, 2024
Duration 1,459 days
Number of Grantees 1
Roles Coordinator
Data Source European Commission
Grant ID 891397
Grant Description

Plant natural products have traditionally provided a great source of chemical scaffolds for the development of new medicines.

Following a downturn in the late 20th century, natural product research is now experiencing a renaissance owing to rapid developments in genomics and metabolomics technologies.

However, the identification of protein targets of newly discovered bioactive natural products remains very low-throughput.

Under this proposal, I will carry out research to develop a new methodology for the elucidation of molecular targets of small bioactive molecules that bind to human proteins such as membrane receptors, using stochastically-generated polymeric probes called iBodies combined with horseradish peroxidase-mediated biotin labeling.

In particular, I will focus on psychoactive metabolites from kava (Piper methysticum) called kavalactones, which have well-documented anti-anxiety properties, but their mechanism of action is unclear.

In the first stage, I will develop the molecular target identification workflow using a previously characterized ligand, resiniferatoxin, which binds with high affinity to the human pain receptor TRPV1.

Once the workflow is developed, I will proceed to identify the brain receptors that are the primary targets of natural kavalactones, as well as non-natural kavalactone derivatives that I recently developed.

In addition, I propose that a similar approach can be applied to identify liver cytochrome P450 enzymes that are inhibited by natural products such as kavalactones.

In the last stage of the project, I will develop a protocol for the extraction of liver proteins and identification of liver enzymes that interact with kavalactones. This research will deliver a new biochemical method for molecular target identification in the short term.

In the long term, it will contribute to the development of novel non-opioid psychiatric therapeutics based on the kavalactone scaffold, thus addressing an urgent need in todays European society.

All Grantees

Ustav Organicke Chemie A Biochemie, Av Cr, V.V.I.

Advertisement
Discover thousands of grant opportunities
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant